| Immune defence to invasive fungal infections: A comprehensive review B Pathakumari, G Liang, W Liu Biomedicine & Pharmacotherapy 130, 110550, 2020 | 191 | 2020 |
| IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis–the most suitable surrogate biomarker for latent TB infection M Prabhavathi, B Pathakumari, A Raja Journal of Infection 71 (2), 238-249, 2015 | 50 | 2015 |
| Altered expression of antigen‐specific memory and regulatory T‐cell subsets differentiate latent and active tuberculosis B Pathakumari, S Devasundaram, A Raja Immunology 153 (3), 325-336, 2018 | 31 | 2018 |
| PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection B Pathakumari, D Anbarasu, RT Parthasarathy, A Raja Tuberculosis 95 (6), 736-743, 2015 | 24 | 2015 |
| Evaluation of cytokine and chemokine response elicited by Rv2204c and Rv0753c to detect latent tuberculosis infection B Pathakumari, M Prabhavathi, A Raja Cytokine 76 (2), 496-504, 2015 | 19 | 2015 |
| Identification of human toll-like receptor 2-agonistic activity in dihydropyridine–quinolone carboxamides Z Hu, J Banothu, M Beesu, CJ Gustafson, MJH Brush, KL Trautman, ... ACS medicinal chemistry letters 10 (1), 132-136, 2018 | 16 | 2018 |
| Genotyping of Mycobacterium leprae for understanding the distribution and transmission of leprosy in endemic provinces of China S Chokkakula, T Shui, H Jiang, J Yang, X Li, J He, L Shen, J Liu, D Wang, ... International Journal of Infectious Diseases 98, 6-13, 2020 | 12 | 2020 |
| Dynamic IgG antibody response to immunodominant antigens of M. tuberculosis for active TB diagnosis in high endemic settings B Pathakumari, M Prabhavathi, D Anbarasu, P Paramanandhan, A Raja Clinica Chimica Acta 461, 25-33, 2016 | 11 | 2016 |
| Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB–a flow cytometry-based analysis B Pathakumari, S Devasundaram, P Maddineni, A Raja International Journal of Medical Microbiology 308 (2), 297-305, 2018 | 7 | 2018 |
| New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease P Escalante, MR Vadiyala, B Pathakumari, PK Marty, VP Van Keulen, ... The International Journal of Tuberculosis and Lung Disease 27 (7), 499-505, 2023 | 2 | 2023 |
| Multiparameter immunoprofiling for the diagnosis and differentiation of progressive versus nonprogressive nontuberculous mycobacterial lung disease–A pilot study PK Marty, B Pathakumari, TM Cox, VP Van Keulen, CL Erskine, M Shah, ... Plos one 19 (4), e0301659, 2024 | 1 | 2024 |
| Biomarker and Therapeutic Targets for Tuberculosis: Role of Micro RNAs B Pathakumari, R Bethunaickan J Investig Genomics 3 (3), 00050, 2016 | 1 | 2016 |
| Evaluation of Candida species-specific T cell immune response in human peripheral blood mononuclear cells B Pathakumari, W Liu, Q Wang, S Chokkakula, V Nunna Authorea Preprints, 2024 | | 2024 |
| Convalescent Adaptive Immunity Is Highly Heterogenous after SARS-CoV-2 Infection * Balaji Pathakumari 1,† , Paige K. Marty 1,†, Maleeha Shah 1 , Virginia P ... Journal of clinical medicine, 12, 7136, 2023 | | 2023 |
| In vitro combination with doxycycline plus antifungals against clinical Mucorales pathogens MZGSHZBPWLG Liang Brazilian Journal of Microbiology, 2023 | | 2023 |
| FLOW CYTOMETRIC IMMUNOPROFILING IN A PATIENT WITH A HYPERMETABOLIC SOLITARY PULMONARY NODULE DUE TO NONTUBERCULOUS MYCOBACTERIAL INFECTION P Arias-Sanchez, MR Vadiyala, S Karnakoti, B Pathakumari, V Vankeulen, ... CHEST 164 (4), A1060-A1061, 2023 | | 2023 |
| BACES SCORE AND TREATMENT OUTCOMES IN PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE MR Vadiyala, E Conley, P Arias-Sanchez, S Karnakoti, P Marty, ... CHEST 164 (4), A887-A888, 2023 | | 2023 |
| Multiparameter cellular and humoral immunoprofiling to differentiate progressive from nonprogressive non-tuberculous mycobacterial lung disease (NTM-LD) B Pathakumari, P Marty, MR Vadiyala, T Cox, V Van Keulen, M Shah, ... The Journal of Immunology 210 (1_Supplement), 81.22-81.22, 2023 | | 2023 |
| Multiparameter immunoprofiling differentiates progressive from nonprogressive nontuberculous mycobacteria lung disease (NTM-LD) P Marty, B Pathakumari, V Van Keulen, M Shah, T Peikert, P Escalante European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
| Therapeutic compounds and methods of use thereof SA David, Y Li, M Brush, K Trautman, C Gustafson, D Maurer, ... US Patent App. 17/256,933, 2021 | | 2021 |
